Highly rated in
Highly rated in
Check Dr. Rocco T. Serrao's experience treating your condition:
About Dr. Rocco T. Serrao

Rocco Serrao is a Dermatologist in Dayton, Ohio. Serrao has been practicing medicine for over 14 years and is highly rated in 10 conditions, according to our data. His top areas of expertise are Actinic Keratosis, Neurocutaneous Melanosis, Ichthyosis Vulgaris, and Epidermoid Cyst. He is licensed to treat patients in Ohio. Serrao is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 6 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rocco T. Serrao it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Rocco T. Serrao accepts the following insurance:

  •  Ambetter
  •  Anthem
  •  CareSource
  •  Oscar
  •  Medical Health

Call to see if your plan is accepted.
5300 Far Hills Ave, Suite 300, Dayton, OH 45429
Other Locations
6480 Harrison Ave, Suite 303, Cincinnati, OH 45247
6110 Radio Way, Mason, OH 45040
45 South Stanfield Road, Troy, OH 45373
Background & Education
Graduate Institution
University Of Pittsburgh School Of Medicine, 2008
Dermatology in OH
Hospital Affiliations
Kettering Health Miamisburg
Joint Township District Memorial Hospital
Mercy Health - West Hospital
Mercer County Community Hospital - Coldwater
The Christ Hospital
Wayne HealthCare
Good Samaritan Hospital
Kettering Health Dayton
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
View 4 Less Clinical Trials -

6 Total Publications

Long-Term Efficacy of Dupilumab in Alopecia Areata.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors